Essilor Luxottica (ESLOF) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning and good afternoon, everybody. This is Giorgio Iannella from the IR team. Thank you for joining SRO Luxottica Interim Results Management Call. The Group Chairman and CEO Francesco Milleri, the Deputy CEO Paul Dusayan and the CFO Stefano Grassi will walk you through the business and financial highlights of the first half of the year. After their presentations, there will be a 30-minute Q&A session. If you want to make a question, please press star followed by five. We kindly ask you to limit your questions to a maximum of two. With that, I hand over to Francesco. Welcome, everyone. I am pleased to reconnect with you to share our first half financial results and update you on our progress in MedTech and wearables. Let's begin with our long-term vision. We believe the future of glasses goes far beyond vision correction. They will become innovative, powerful, AI-enabled platforms that support human performance and healthcare at various levels. Thanks to our unique scale, capability, and global reach, we are in a position to lead this transformation. As a vertically integrated group, we are developing smart eyewear that combines vision care with digital functionalities. With access every year to over half a billion customers, we have the ability to collect a huge amount of data we are positioned to further innovate in many fields such as diagnostics, early disease detection and high health, even identifying health risks, for example in neurodegenerative and cardiovascular areas. Our ambition is to become the world's leading processor of healthcare metrics using a network of smart eyewear equipped with sensors and cameras to collect and analyze information. This is the core of our MedTech strategy and the destination of our long-term journey. Now, looking at o...